Danaher Co. (NYSE:DHR) Shares Sold by Connable Office Inc.

Connable Office Inc. trimmed its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 11.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,504 shares of the conglomerate's stock after selling 1,626 shares during the period. Connable Office Inc.'s holdings in Danaher were worth $2,870,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. AMF Tjanstepension AB bought a new stake in shares of Danaher in the 3rd quarter valued at about $5,923,000. Howard Capital Management Group LLC boosted its holdings in shares of Danaher by 4.1% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate's stock valued at $342,000 after buying an additional 48 shares in the last quarter. Mutual Advisors LLC boosted its holdings in shares of Danaher by 6.4% in the 3rd quarter. Mutual Advisors LLC now owns 6,478 shares of the conglomerate's stock valued at $1,801,000 after buying an additional 390 shares in the last quarter. SteelPeak Wealth LLC boosted its holdings in shares of Danaher by 5.7% in the 3rd quarter. SteelPeak Wealth LLC now owns 1,420 shares of the conglomerate's stock valued at $395,000 after buying an additional 76 shares in the last quarter. Finally, Oak Ridge Investments LLC boosted its holdings in shares of Danaher by 7.2% in the 3rd quarter. Oak Ridge Investments LLC now owns 24,235 shares of the conglomerate's stock valued at $6,738,000 after buying an additional 1,626 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Activity

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on DHR shares. Raymond James restated a "market perform" rating on shares of Danaher in a report on Monday, February 3rd. Bank of America upgraded shares of Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price target on the stock in a report on Friday, December 13th. Robert W. Baird lowered their target price on shares of Danaher from $277.00 to $268.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. The Goldman Sachs Group set a $250.00 target price on shares of Danaher in a research note on Wednesday, January 15th. Finally, Guggenheim began coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a "buy" rating and a $275.00 target price for the company. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $278.00.

Danaher Stock Performance

Shares of NYSE:DHR traded up $0.23 during trading on Tuesday, hitting $205.92. 5,652,379 shares of the stock traded hands, compared to its average volume of 4,574,931. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a market cap of $147.17 billion, a price-to-earnings ratio of 39.00, a P/E/G ratio of 2.66 and a beta of 0.82. The company has a fifty day moving average price of $223.61 and a two-hundred day moving average price of $243.86. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the business posted $2.09 earnings per share. As a group, equities analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. This is a positive change from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher's payout ratio is 24.24%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.